Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
How Do Gut Microbes Shape Immunity? Interview with Dennis Lee Kasper
10
Mins
January 2025
It takes an interdisciplinary approach to solve complex problems in the microbiome because you couldn’t ask for a more complex system.
Read more
8
Mins
4 Apr 2022
Molecular Characterisation of Diarrhoeagenic
Escherichia coli
Isolated from Captive and Free-Ranging Olive Baboons (
Papio anubis
) Faecal Samples
Escherichia coli is a normal inhabitant of the mammalian gut, but it also exists in a number of pathogenic forms. Diarrhoeagenic E. coli…
4
Mins
28 Mar 2022
Interview: David Heymann CBE
David Heymann CBE shared his expertise with EMJ on public health and epidemiology, in the context of COVID-19 and previous disease outbreaks…
11
Mins
28 Mar 2022
Interview: Ron Daniels
Ron Daniels offered insights to EMJ on the latest developments in sepsis care, and a look to the future for optimal diagnosis…
5
Mins
22 Mar 2022
Science Versus COVID-19: What Have We Learnt So Far?
TWO YEARS AGO, the COVID-19 pandemic emerged and swept through the world, going on to have a profound human and health toll…
6
Mins
22 Mar 2022
Editor’s Pick: Thromboembolic Storm in the Recovering Stage of COVID-19: A Case Report
COVID 19 was first identified in late 2019 and led to a worldwide pandemic. Covid complications include thromboembolic storm…
4
Mins
15 Feb 2022
Aspergillus terreus
Peritonitis in a Child on Continuous Ambulatory Peritoneal Dialysis: A Case Report from Pakistan
Continuous ambulatory peritoneal dialysis (CAPD) is a well-known management technique for paediatric Stage 5 chronic kidney disease (CKD-5)…
4
Mins
28 Jan 2022
Trends in Infectious Diseases: A Retrospective 5-Year Study
A wide variety of infections contribute to acute care admissions to general internal medical units.
7
Mins
10 Jan 2022
Aviptadil: Class Effect of a Synthetic Vasoactive Intestinal Peptide as a Treatment Option in Patients with COVID-19 with Severe Respiratory Failure
Aviptadil has already proved to be an effective option in the treatment of severe respiratory failures due to sepsis and other related lung injuries. The final results from a recently completed trial, as well as all currently ongoing trials, will clarify the class effect of this drug in the treatment of COVID-19 in future days.
Loading posts...
« Previous
1
…
5
6
7
8
9
10
Next »